Journal of Surgery Concepts & Practice ›› 2020, Vol. 25 ›› Issue (03): 227-233.doi: 10.16139/j.1007-9610.2020.03.011
• Original article • Previous Articles Next Articles
GAO Hang, ZHAO Feng, WU Yan, PEI Wenjiang, ZHONG Ming, GU Yan, GUO Shanyu, DAI Qiancheng, ZHANG Wei()
Received:
2019-11-04
Online:
2020-05-25
Published:
2020-05-25
CLC Number:
GAO Hang, ZHAO Feng, WU Yan, PEI Wenjiang, ZHONG Ming, GU Yan, GUO Shanyu, DAI Qiancheng, ZHANG Wei. Study on microRNA-9-5p reducing sensitivity of breast cancer cells to doxorubicin through targeting HIC1[J]. Journal of Surgery Concepts & Practice, 2020, 25(03): 227-233.
[1] |
Adachi Y, Yoshimura M, Nishida K, et al. Acute phase dynamics of circulating tumor cells after paclitaxel and doxorubicin chemotherapy in breast cancer mouse models[J]. Breast Cancer Res Treat, 2018, 167(2):439-450.
doi: 10.1007/s10549-017-4532-x URL |
[2] |
Zhang Y, Xia F, Zhang F, et al. miR-135b-5p enhances doxorubicin-sensitivity of breast cancer cells through targeting anterior gradient 2[J]. J Exp Clin Cancer Res, 2019, 38(1):26.
doi: 10.1186/s13046-019-1024-3 URL |
[3] |
Chewchuk S, Guo B, Parissenti AM. Alterations in estrogen signaling pathways upon acquisition of anthracycline resistance in breast tumor cells[J]. PLoS One, 2017, 12(2):e0172244.
doi: 10.1371/journal.pone.0172244 URL |
[4] |
Liu DZ, Chang B, Li XD, et al. MicroRNA-9 promotes the proliferation, migration, and invasion of breast cancer cells via down-regulating FOXO1[J]. Clin Transl Oncol, 2017, 19(9):1133-1140.
doi: 10.1007/s12094-017-1650-1 pmid: 28397066 |
[5] |
Zhao F, Pan S, Gu Y, et al. Reactivation of HIC1 gene by saRNA inhibits clonogenicity and invasiveness in breast cancer cells[J]. Oncol lett, 2015, 9(1):159-164.
doi: 10.3892/ol.2014.2633 URL |
[6] |
Feng F, Zhu X, Wang C, et al. Downregulation of hypermethylated in cancer-1 by miR-4532 promotes adria-mycin resistance in breast cancer cells[J]. Cancer Cell Int, 2018, 18:127.
doi: 10.1186/s12935-018-0616-x pmid: 30202238 |
[7] |
Rivankar S. An overview of doxorubicin formulations in cancer therapy[J]. J Cancer Res and Ther, 2014, 10(4):853-858.
doi: 10.4103/0973-1482.139267 URL |
[8] | Wang S, Oh DY, Leventaki V, et al. MicroRNA-17 acts as a tumor chemosensitizer by targeting JAB1/CSN5 in triple-negative breast cancer[J]. Cancer Lett, 2019,465:12-23. |
[9] |
Lin H, Gregory JH. MicroRNAs: small RNAs with a big role in gene regulation[J]. Nat Rev Genet, 2004, 5(7):522-531.
doi: 10.1038/nrg1379 pmid: 15211354 |
[10] |
Dong H, Lei J, Ding L, et al. MicroRNA: function, detection, and bioanalysis[J]. Chem Rev, 2013, 113(8):6207-6233.
doi: 10.1021/cr300362f URL |
[11] |
Piasecka D, Braun M, Kordek R, et al. MicroRNAs in regulation of triple-negative breast cancer progression[J]. J Cancer Res Clin Oncol, 2018, 144(8):1401-1411.
doi: 10.1007/s00432-018-2689-2 URL |
[12] |
Gulyaeva LF, Kushlinskiy NE. Regulatory mechanisms of microRNA expression[J]. J Transl Med, 2016, 14(1):143.
doi: 10.1186/s12967-016-0893-x URL |
[13] |
Rivera-Barahona A, Pérez B, Richard E, et al. Role of miRNAs in human disease and inborn errors of metabolism[J]. J Inherit Metab Dis, 2017, 40(4):471-480.
doi: 10.1007/s10545-017-0018-6 pmid: 28229250 |
[14] |
Madelaine R, Sloan SA, Huber N, et al. MicroRNA-9 couples brain neurogenesis and angiogenesis[J]. Cell Rep, 2017, 20(7):1533-1542.
doi: S2211-1247(17)31030-6 pmid: 28813666 |
[15] |
Li G, Wu F, Yang H, et al. MiR-9-5p promotes cell growth and metastasis in non-small cell lung cancer through the repression of TGFBR2[J]. Biomed Pharmacother, 2017, 96:1170-1178.
doi: 10.1016/j.biopha.2017.11.105 URL |
[16] |
Sondermann A, Andreghetto FM, Moulatlet AC, et al. MiR-9 and miR-21 as prognostic biomarkers for recurrence in papillary thyroid cancer[J]. Clin Exp Metastasis, 2015, 32(6):521-530.
doi: 10.1007/s10585-015-9724-3 URL |
[17] |
Yi J, Gao ZF. MicroRNA-9-5p promotes angiogenesis but inhibits apoptosis and inflammation of high glucose-induced injury in human umbilical vascular endothelial cells by targeting CXCR4[J]. Int J Biol Macromol, 2019, 130:1-9.
doi: 10.1016/j.ijbiomac.2019.02.003 URL |
[18] | Zhang H, Zhang Z, Wang S, et al. The mechanisms involved in miR-9 regulated apoptosis in cervical cancer by targeting FOXO3[J]. Biomed Pharmacother, 2018,102:626-632. |
[19] |
Wang H, Zhang W, Zuo Y, et al. miR-9 promotes cell proliferation and inhibits apoptosis by targeting LASS2 in bladder cancer[J]. Tumour Biol, 2015, 36(12):9631-9640.
doi: 10.1007/s13277-015-3713-7 URL |
[20] | Polley E, Kunkei M, Evans D, et al. Small cell lung cancer screen of oncology drugs, investigational agents, and gene and microRNA expression[J]. J Natl Cancer Inst, 2016, 108(10) |
[21] |
Barbano R, Pasculli B, Rendina M, et al. Stepwise analysis of MIR9 loci identifies miR-9-5p to be involved in Oestrogen regulated pathways in breast cancer patients[J]. Sci Rep, 2017, 7:45283.
doi: 10.1038/srep45283 URL |
[22] |
Wales MM, Biel MA, Deiry WE, et al. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3[J]. Nat Med, 1995, 1(6):570-577.
pmid: 7585125 |
[23] |
Szczepny A, Carey K, Mckenzie L, et al. The tumor suppressor Hic1 maintains chromosomal stability independent of Tp53[J]. Oncogene, 2018, 37(14):1939-1948.
doi: 10.1038/s41388-017-0022-1 pmid: 29367758 |
[24] |
Li P, Liu X, Dong ZM, et al. Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma[J]. Oncotarget, 2015, 6(35):38151-38165.
doi: 10.18632/oncotarget.5832 URL |
[25] |
Zhou X, Zhang P, Han H, et al. Hypermethylated in cancer 1 (HIC1) suppresses bladder cancer progression by targeting yes-associated protein (YAP) pathway[J]. J Cell Biochem, 2019, 120(4):6471-6481.
doi: 10.1002/jcb.27938 URL |
[1] | YE Zhiliang, LI Canbing, ZHANG Yongjun, LI Licheng, XIAO Yinjing, WU Yuhang, TAI Nengling. Optimization of Day-Ahead Dispatch Time Resolution in Power System with a High Proportion of Climate-Sensitive Renewable Energy Sources [J]. Journal of Shanghai Jiao Tong University, 2023, 57(7): 781-790. |
[2] | LI Hui, YIN Yu, LI Chunxiao, et al. Research progress on rehabilitation effect of respiratory training on breast cancer-related lymphedema [J]. Journal of Tissue Engineering and Reconstructive Surgery, 2023, 19(4): 430-. |
[3] | ZHU Danli, BAO Wanting, WEI Hao, et al. Advances in breast reconstruction after breast cancer surgery [J]. Journal of Tissue Engineering and Reconstructive Surgery, 2023, 19(2): 201-. |
[4] | SI Shengping, GUO Qiang, YANG Lin, ZHOU Chun, WANG Rui. Channel Performance Analysis of High-Sensitivity Receiver [J]. Air & Space Defense, 2023, 6(1): 78-84. |
[5] | ZHU Qiaoli, MIAO Yiming, CHEN Xiaosong. Prognostic analysis of breast-conserving surgery or mastectomy in patients with stage Ⅰ-Ⅲ triple-negative breast cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(04): 371-377. |
[6] | YANG Yi, YANG Xingxia, JIN Sili, ZHANG Xu, ZHU Juanying, CHEN Xiaosong. Clinical application of preoperative MRI examination in breast-conserving surgery for ductal carcinoma in situ [J]. Journal of Surgery Concepts & Practice, 2023, 28(04): 378-382. |
[7] | DONG Jun, CUI Fengming, LIU Jun. Effects of silencing Ki-67 gene on doxorubicin resistance of breast cancer MCF-7/DOX cells [J]. Journal of Surgery Concepts & Practice, 2023, 28(03): 254-259. |
[8] | GAO Weiqi, ZHANG Xu, WANG Zheng, ZHU Yifei, HUANG Jiahui, HONG Jin, ZHU Siji, CHEN Xiaosong, HUANG Ou, HE Jianrong, CHEN Weiguo, LI Yafen, SHEN Kunwei, XU Hua, WU Jiayi. Safety analysis of immediate breast reconstruction with deep inferior epigastric perforator after neoadjuvant treatment [J]. Journal of Surgery Concepts & Practice, 2023, 28(02): 147-151. |
[9] | FANG Xiaotao, YAN Zheng, WANG Han, XU Xiaoyuan, CHEN Yue. A Shared Energy Storage Optimal Operation Method Considering the Risk of Probabilistic Voltage Unbalance Factor Limit Violation [J]. Journal of Shanghai Jiao Tong University, 2022, 56(7): 827-839. |
[10] | WU Shuchen, QI Zongfeng, LI Jianxun. Intelligent Global Sensitivity Analysis Based on Deep Learning [J]. Journal of Shanghai Jiao Tong University, 2022, 56(7): 840-849. |
[11] |
ZHANG Xiaoli, LI Zan, SONG Dajiang, et al.
Clinical application of the pedicled lateral thoracic artery perforation flap in breast reconstruction immediately after breast-conserving surgery [J]. Journal of Tissue Engineering and Reconstructive Surgery, 2022, 18(5): 382-. |
[12] |
SONG Dajiang, LI Zan, ZHANG Yixin.
Surgical strategy of huge chest wall defect reconstruction using pedicled rectus abdominis musculocutaneous flap combined with free deep inferior epigastric artery perforator flap [J]. Journal of Tissue Engineering and Reconstructive Surgery, 2022, 18(5): 386-. |
[13] |
CHEN Kuo, SONG Dajiang, MU Lan, et al.
Repair of abdominal wall donor site defect of TRAM by freeing the anterior rectus sheath of superior rectus abdominis -- An attempt to make patch with autologous tissue [J]. Journal of Tissue Engineering and Reconstructive Surgery, 2022, 18(5): 393-. |
[14] | LIU Min (刘 敏), YI Ming (易 鸣), WU Minghu∗ (武明虎), WANG Juan (王 娟), HE Yu (何 宇). Breast Pathological Image Classification Based on VGG16 Feature Concatenation [J]. J Shanghai Jiaotong Univ Sci, 2022, 27(4): 473-484. |
[15] |
YAO Chengcai, CHEN Ming, LIU Changchun, et al.
Application of silicone gel breast prosthesis combined with titanium polypropylene mesh in immediate breast reconstruction for early breast cancer [J]. Journal of Tissue Engineering and Reconstructive Surgery, 2022, 18(3): 247-. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||